Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1[PREDNISOLONE]
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
2Azathioprine + Prednisolone
(D00472)		[2] Azathioprine,
Prednisolone		[3] Azathioprine ,
Prednisolone (D00472),
Azathioprine sodium 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 95 💬
3AZD4017 and prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 75 💬
4Co-intervention of Prednisolone wean during open label extension phase
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
5Co-intervention of Prednisolone wean during randomised controlled phase
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
6Combination therapy with vigabatrin and prednisolone
(D00472)		[2] Prednisolone,
Vigabatrin		[2] Prednisolone (D00472),
Vigabatrin 💬 		[2] ABAT,
NR3C1 💬 		[7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 145 💬
7Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
(D00472)		[7] Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		[8] Hydrocortisone ,
Dexamethasone ,
Prednisolone (D00472),
Prednisone ,
Cortisone acetate ,
Dexamethasone sodium phosphate ,
Cortisone ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
8Corticosteroid treatment (Methylprednisolone or prednisolone)
(D00472)		[2] Methylprednisolone,
Prednisolone		[3] Methylprednisolone ,
Prednisolone (D00472),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 64 💬
9Corticosteroids (prednisone or prednisolone)
(D00472)		[2] Prednisolone,
Prednisone		[2] Prednisolone (D00472),
Prednisone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 49, 223 💬
10Etanercept, Methotrexate, Prednisolone
(D00472)		[3] Etanercept,
Methotrexate,
Prednisolone		[4] Methotrexate ,
Prednisolone (D00472),
Etanercept ,
Methotrexate sodium 💬 		[5] DHFR,
DHFR2,
LTA,
NR3C1,
TNF 💬 		[70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 56 💬
11Fast prednisolone taper
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
12Glucocorticoid (prednisone or prednisolone)
(D00472)		[2] Prednisolone,
Prednisone		[2] Prednisolone (D00472),
Prednisone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
13Intravenous methyl prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 43 💬
14Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP
(D00472)		[4] Dapsone,
Mycophenolate mofetil,
Prednisolone,
Triamcinolone		[8] Triamcinolone ,
Prednisolone (D00472),
Dapsone ,
Mycophenolate mofetil ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide ,
Mycophenolate mofetil hydrochloride 💬 		[3] IMPDH1,
IMPDH2,
NR3C1 💬 		[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 162 💬
15Lodotra (delayed release prednisolone)
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
16Long term tapering of prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
17Long-circulating liposomal prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
18Low dose prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
19Medium dose prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
20Methotrexate - etanercept - prednisolone arm
(D00472)		[3] Etanercept,
Methotrexate,
Prednisolone		[4] Methotrexate ,
Prednisolone (D00472),
Etanercept ,
Methotrexate sodium 💬 		[5] DHFR,
DHFR2,
LTA,
NR3C1,
TNF 💬 		[70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 46, 107 💬
21Methyl prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 43, 49, 96 💬
22Methylprednisolone or Prednisolone
(D00472)		[2] Methylprednisolone,
Prednisolone		[3] Methylprednisolone ,
Prednisolone (D00472),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
23Mycophenolate Mofetil + Prednisolone Participants will receive mycophenolate mofetil in combination.
(D00472)		[2] Mycophenolate mofetil,
Prednisolone		[3] Prednisolone (D00472),
Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		[3] IMPDH1,
IMPDH2,
NR3C1 💬 		[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 95 💬
24Oral prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 49, 96, 145 💬
25Oral prednisolone and cyclophosphamide
(D00472)		[2] Cyclophosphamide,
Prednisolone		[3] Cyclophosphamide ,
Prednisolone (D00472),
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
26Oral prednisolone and SoC
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
27Oral prednisolone Taper
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
28Overencapsulated Prednisolone Tablets
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
29Paroxetine & Prednisolone
(D00472)		[2] Paroxetine,
Prednisolone		[5] Prednisolone (D00472),
Paroxetine hydrochloride hemihydrate ,
Paroxetine ,
Paroxetine hydrochloride ,
Paroxetine mesylate 💬 		[2] NR3C1,
SLC6A4 💬 		[4] Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46 💬
30Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP
(D00472)		[2] Paroxetine,
Prednisolone		[5] Prednisolone (D00472),
Paroxetine hydrochloride hemihydrate ,
Paroxetine ,
Paroxetine hydrochloride ,
Paroxetine mesylate 💬 		[2] NR3C1,
SLC6A4 💬 		[4] Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46 💬
31Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP
(D00472)		[2] Paroxetine,
Prednisolone		[5] Prednisolone (D00472),
Paroxetine hydrochloride hemihydrate ,
Paroxetine ,
Paroxetine hydrochloride ,
Paroxetine mesylate 💬 		[2] NR3C1,
SLC6A4 💬 		[4] Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46 💬
32PEG-liposomal Prednisolone Sodium Phosphate
(D00472)		[2] Prednisolone,
Prednisolone phosphate		[2] Prednisolone (D00472),
Prednisolone sodium phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 97 💬
33Prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[48] 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
34Prednisolone & dipyridamole
(D00472)		[2] Dipyridamole,
Prednisolone		[2] Dipyridamole ,
Prednisolone (D00472) 💬 		[3] NR3C1,
PDE4A,
PDE5A 💬 		[6] Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 46 💬
35Prednisolone + mabthera
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 61 💬
36PREDNISOLONE - prednisolone tablet
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
37Prednisolone 1mg Tablets
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
38Prednisolone 2,5 mg Tablets
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
39Prednisolone 20 mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
40Prednisolone 40 mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
41Prednisolone 5 mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 46, 51 💬
42Prednisolone 5 mg Tablets
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
43Prednisolone 5mg Gastro-resistant Tablets
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 51 💬
44Prednisolone 5mg Tablet
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
45PREDNISOLONE ACETATE
(D00472)		[3] Acetate,
Prednisolone,
Prednisolone acetate		[2] Prednisolone (D00472),
Prednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 222, 223 💬
46Prednisolone and chlorambucil
(D00472)		[2] Chlorambucil,
Prednisolone		[2] Chlorambucil ,
Prednisolone (D00472) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 222, 223 💬
47Prednisolone and mycophenolate mofetil
(D00472)		[2] Mycophenolate mofetil,
Prednisolone		[3] Prednisolone (D00472),
Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		[3] IMPDH1,
IMPDH2,
NR3C1 💬 		[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[2] 222, 223 💬
48Prednisolone and tacrolimus
(D00472)		[2] Prednisolone,
Tacrolimus		[3] Tacrolimus ,
Prednisolone (D00472),
Tacrolimus 💬 		[6] NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 223 💬
49Prednisolone and taper
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 51 💬
50Prednisolone Labesfal
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
51Prednisolone plus Cyclophosphamide
(D00472)		[2] Cyclophosphamide,
Prednisolone		[3] Cyclophosphamide ,
Prednisolone (D00472),
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
52Prednisolone sodium metasulphobenzoate
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
53PREDNISOLONE SODIUM PHOSPHATE
(D00472)		[2] Prednisolone,
Prednisolone phosphate		[2] Prednisolone (D00472),
Prednisolone sodium phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 3, 13, 97 💬
54Prednisolone Sodium Phosphate Oral Solution
(D00472)		[2] Prednisolone,
Prednisolone phosphate		[2] Prednisolone (D00472),
Prednisolone sodium phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 3 💬
55PREDNISOLONE SODIUM SUCCINATE
(D00472)		[3] Prednisolone,
Prednisolone hemisuccinate,
Succinic acid		[3] Prednisolone (D00472),
Prednisolone sodium succinate ,
Prednisolone hemisuccinate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 95 💬
56Prednisolone solution 5mg/ml
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 222, 223 💬
57Prednisolone Tablets B.P. 5mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
58Prednisolone Tablets BP
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
59Prednisolone Tablets BP 1 mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
60Prednisolone Tablets USP 5 mg
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
61Prednisolone-Dipyridamole
(D00472)		[2] Dipyridamole,
Prednisolone		[2] Dipyridamole ,
Prednisolone (D00472) 💬 		[3] NR3C1,
PDE4A,
PDE5A 💬 		[6] Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 46 💬
62Prednisolone/Prednisone
(D00472)		[2] Prednisolone,
Prednisone		[2] Prednisolone (D00472),
Prednisone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
63Prednisone or Prednisolone
(D00472)		[2] Prednisolone,
Prednisone		[2] Prednisolone (D00472),
Prednisone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 84 💬
64Prednisone/Prednisolone
(D00472)		[2] Prednisolone,
Prednisone		[2] Prednisolone (D00472),
Prednisone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 11, 35 💬
65Pyridoxine plus prednisolone
(D00472)		[2] Prednisolone,
Pyridoxine		[3] Prednisolone (D00472),
Pyridoxine hydrochloride ,
Pyridoxine 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 145 💬
66Short-Duration Oral Prednisolone with Extended Tapering
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 145 💬
67SOLUBLE PREDNISOLONE TABLETS
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 145 💬
68Standard Oral Prednisolone Regimen with Tapering
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 145 💬
69Standard prednisolone taper
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
70Standard prednisolone treatment
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
71Trexan+Salazopyrin+Oxiklorin+prednisolone
(D00472)		[1] Prednisolone[1] Prednisolone (D00472) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
72Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab
(D00472)		[2] Infliximab,
Prednisolone		[2] Prednisolone (D00472),
Infliximab 💬 		[2] NR3C1,
TNF 💬 		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
73Z102 (Prednisolone and Dipyridamole).
(D00472)		[2] Dipyridamole,
Prednisolone		[2] Dipyridamole ,
Prednisolone (D00472) 💬 		[3] NR3C1,
PDE4A,
PDE5A 💬 		[6] Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 46 💬